Business Description
Daiken Medical Co Ltd
ISIN : JP3482500000
Description
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.28 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.34 | |||||
| Debt-to-EBITDA | 1.71 | |||||
| Interest Coverage | 298.99 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 4.5 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | 11.2 | |||||
| 3-Year EPS without NRI Growth Rate | 13.4 | |||||
| 3-Year FCF Growth Rate | 67.1 | |||||
| 3-Year Book Growth Rate | 4.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.42 | |||||
| 9-Day RSI | 57.74 | |||||
| 14-Day RSI | 52.51 | |||||
| 6-1 Month Momentum % | -5.82 | |||||
| 12-1 Month Momentum % | -10.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.36 | |||||
| Quick Ratio | 1.9 | |||||
| Cash Ratio | 1.04 | |||||
| Days Inventory | 93.1 | |||||
| Days Sales Outstanding | 47.38 | |||||
| Days Payable | 30.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.17 | |||||
| Dividend Payout Ratio | 0.35 | |||||
| 3-Year Dividend Growth Rate | 1.6 | |||||
| Forward Dividend Yield % | 5.16 | |||||
| 5-Year Yield-on-Cost % | 4.37 | |||||
| Shareholder Yield % | 6.36 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.84 | |||||
| Operating Margin % | 14.8 | |||||
| Net Margin % | 10.14 | |||||
| FCF Margin % | 14.22 | |||||
| ROE % | 14.1 | |||||
| ROA % | 8.82 | |||||
| ROIC % | 13.03 | |||||
| 3-Year ROIIC % | -88.84 | |||||
| ROC (Joel Greenblatt) % | 22.51 | |||||
| ROCE % | 18.41 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.64 | |||||
| PE Ratio without NRI | 14.52 | |||||
| PEG Ratio | 8.54 | |||||
| PS Ratio | 1.49 | |||||
| PB Ratio | 1.98 | |||||
| Price-to-Tangible-Book | 1.99 | |||||
| Price-to-Free-Cash-Flow | 10.44 | |||||
| Price-to-Operating-Cash-Flow | 9.31 | |||||
| EV-to-EBIT | 9.57 | |||||
| EV-to-EBITDA | 9.57 | |||||
| EV-to-Revenue | 1.42 | |||||
| EV-to-FCF | 9.82 | |||||
| Price-to-GF-Value | 0.85 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Median-PS-Value | 1.41 | |||||
| Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 4.75 | |||||
| Earnings Yield (Greenblatt) % | 10.45 | |||||
| FCF Yield % | 9.57 | |||||
| Forward Rate of Return (Yacktman) % | 7.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daiken Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 9,750.166 | ||
| EPS (TTM) (円) | 34.406 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.12 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 7.32 | ||
| 14-Day RSI | 52.51 | ||
| 14-Day ATR (円) | 5.057719 | ||
| 20-Day SMA (円) | 500.55 | ||
| 12-1 Month Momentum % | -10.2 | ||
| 52-Week Range (円) | 452 - 585 | ||
| Shares Outstanding (Mil) | 28.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Daiken Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Daiken Medical Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Daiken Medical Co Ltd Frequently Asked Questions
What is Daiken Medical Co Ltd(TSE:7775)'s stock price today?
The current price of TSE:7775 is 円504.00. The 52 week high of TSE:7775 is 円585.00 and 52 week low is 円452.00.
When is next earnings date of Daiken Medical Co Ltd(TSE:7775)?
The next earnings date of Daiken Medical Co Ltd(TSE:7775) is .
Does Daiken Medical Co Ltd(TSE:7775) pay dividends? If so, how much?
The Dividend Yield %  of Daiken Medical Co Ltd(TSE:7775) is 4.17% (As of Today), Highest Dividend Payout Ratio of Daiken Medical Co Ltd(TSE:7775) was 0.84. The lowest was 0.35. And the median was 0.62. The  Forward Dividend Yield % of Daiken Medical Co Ltd(TSE:7775) is 5.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers